// company-profile
Damora Therapeutics, Inc.
DMRAExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings53Insiders29
// api This Damora Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, Damora Therapeutics, Inc. insiders bought $0 across 2 transactions with no open-market sales.
- Most active insider: Jarrett Jennifer with 2 transactions totaling $0.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Damora Therapeutics, Inc. as of 2026-03-31
Total reported AUM
$1.45B
QoQ change
—
Reporting period
2026-03-31
#1
Fairmount Funds Management LLC
CIK 1802528
$225.7M
8.7M shares
#2
FMR LLC
CIK 315066
$168.9M
6.5M shares
#3
Avoro Capital Advisors LLC
CIK 1633313
$98.0M
3.8M shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Jarrett Jennifer | DMRA | Award | 1,500,000 | $0.00 | $0K |
| Mar 30, 2026 | Jarrett Jennifer | DMRA | Award | 500,000 | $0.00 | $0K |
| Mar 23, 2026 | Bruno Julianne | DMRA | Award | 37,313 | $0.00 | $0K |
| Mar 23, 2026 | Landsittel Michael | DMRA | Award | 37,313 | $0.00 | $0K |
| Mar 23, 2026 | CAIN CHRISTOPHER W. | DMRA | Award | 37,313 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.